AXIN 2 Polymorphisms , the β-Catenin Destruction Complex Expression Profile and Breast Cancer Susceptibility

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Peripheral Blood Gene Expression Profile Based on Her2 Expression on Primary Tumors of Breast Cancer Patients

  2014influential reference
• Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling

  2014cited by this paper
• Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.

  2014cited by this paper
• Nuclear AXIN2 represses MYC gene expression.

  2014cited by this paper
• The axis inhibition protein 2 polymorphisms and non-syndromic orofacial clefts susceptibility in a Chinese Han population.

  2014cited by this paper
• GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug

  2014cited by this paper
• Wnt Pathway Activity in Breast Cancer Sub-Types and Stem-Like Cells

  2013influential reference
• The β-catenin destruction complex.

  2013cited by this paper
• An Analysis of Polymorphisms Within the Wnt Signaling Pathway in Relation to Ovarian Cancer Risk in a Polish Population

  2013cited by this paper
• Interactions and functions of the adenomatous polyposis coli (APC) protein at a glance

  2013cited by this paper
• Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes with Breast Cancer in Saudi Patients

  2013influential reference
• Development of an eight gene expression profile implicating human breast tumours of all grade

  2012influential reference
• Activation Status of Wnt/ß-Catenin Signaling in Normal and Neoplastic Breast Tissues: Relationship to HER2/neu Expression in Human and Mouse

  2012cited by this paper
• Lung Cancer Signature Biomarkers: tissue specific semantic similarity based clustering of Digital Differential Display (DDD) data

  2012cited by this paper
• Wnt/β-catenin signaling and disease.

  2012influential reference
• Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

  2011cited by this paper
• AXIN2 germline mutations are rare in familial melanoma

  2011cited by this paper
• AXIN2 polymorphism and its association with prostate cancer in a Turkish population

  2011cited by this paper
• Identification of genetic alterations of AXIN2 gene in adrenocortical tumors.

  2011influential reference
• Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women

  2010cited by this paper
• Wnt/beta-catenin signaling: components, mechanisms, and diseases.

  2009influential reference
• β-Catenin hits chromatin: regulation of Wnt target gene activation

  2009cited by this paper
• Survival of breast cancer women in the state of Rio de Janeiro, Southeastern Brazil.

  2009influential reference
• Strong association between lung cancer and the AXIN2 polymorphism.

  2009influential reference
• DNA repair in Etoposide-induced DNA damage in lymphocytes of breast cancer patients and healthy women.

  2009cited by this paper
• AXIN2 and CDH1 polymorphisms, tooth agenesis, and oral clefts.

  2009cited by this paper
• Epigenetic gene silencing in the Wnt pathway in breast cancer

  2008cited by this paper
• Association of Genetic Variation in Genes Implicated in the β-Catenin Destruction Complex with Risk of Breast Cancer

  2008influential reference
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma

  2008influential reference
• Multiple pathways regulated by the tumor suppressor PP2A in transformation.

  2008cited by this paper
• The many ways of Wnt in cancer.

  2007cited by this paper
• The tumor suppressor PP2A Abeta regulates the RalA GTPase.

  2007cited by this paper
• A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.

  2006cited by this paper
• Single nucleotide polymorphism of the AXIN2 gene is preferentially associated with human lung cancer risk in a Japanese population.

  2006influential reference
• Axis inhibition protein 2 (AXIN2) polymorphisms may be a risk factor for selective tooth agenesis

  2006cited by this paper
• Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines

  2006cited by this paper
• The links between axin and carcinogenesis

  2005influential reference
• WNT and beta-catenin signalling: diseases and therapies.

  2004influential reference
• Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer.

  2004cited by this paper
• Wnt Signaling and Breast Cancer

  2004influential reference
• [Cloning and expression analysis of lung carcinoma related gene HLCDG1].

  2003cited by this paper
• Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors

  2002influential reference
• Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway

  2002cited by this paper
• Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene

  2001cited by this paper
• Involvement of adenomatous polyposis coli (APC)/β-catenin signalling in human breast cancer

  2000cited by this paper
• Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.

  1999cited by this paper
• Stabilization of beta-catenin by genetic defects in melanoma cell lines.

  1997cited by this paper

• No citing papers are available for this paper.